Loading
Milan research foundation, led by Luca Gianni, that designs and runs academic breast cancer trials such as NeoSphere and the neoadjuvant HER2 studies.
The Fondazione Michelangelo is an independent, not-for-profit clinical research organisation in Milan founded to run investigator-led cancer trials, chiefly in breast cancer. Under its president Luca Gianni it has coordinated the NeoSphere, NOAH and neoadjuvant biomarker studies that helped establish pathological complete response as an endpoint for HER2-positive breast cancer, and it collaborates with the Fondazione IRCCS Istituto Nazionale dei Tumori and hospitals across Italy.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Fondazione Michelangelo, including child institutions. 27 works · 1,039 citations · 70% open access · 4% clinical trials · 0% reviews.